US Stock Futures Up; All Eyes On Jobs Report
US stock futures traded higher in early pre-market trade. Data on non-farm payrolls for September will be released at 8:30 a.m. ET, while factory orders data for August will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average jumped 55.5 points to 16,245.5, while the Standard & Poor's 500 index futures rose 6 points to 1,922.75. Futures for the Nasdaq 100 index surged 19.75 points to 4,207.25.
A Peek Into Global Markets
European markets were higher today, with the Spanish Ibex Index gaining 1.03 percent, STOXX Europe 600 Index jumping 1.52 percent and German DAX 30 index gaining 1.46 percent. French CAC 40 Index rose 1.80 percent and London's FTSE 100 Index rose 1.55 percent.
In Asian markets, Japan's Nikkei Stock Average rose 0.02 percent and Hong Kong's Hang Seng Index gained 3.17 percent.
Analysts at Oppenheimer upgraded Google Inc (NASDAQ: GOOG) from Perform to Outperform and raised the price target from $670.00 to $700.00.
Google shares rose 0.80 percent to $616.16 in pre-market trading.
- Sandoz, a Novartis AG (ADR) (NYSE: NVS) company and the global leader in biosimilars, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen, Inc.'s (NASDAQ: AMGN) US-licensed Enbrel®* (etanercept) - a tumor necrosis factor alpha (TNF-alpha) inhibitor. To read the full news, click here.
- Applied Industrial Technologies (NYSE: AIT) today announced it has acquired S. G. Morris Co. (SGM), a distributor of fluid power components and provider of engineered fluid power systems. To read the full news, click here.
- Micron Technology, Inc. (NASDAQ: MU) reported better-than-expected earnings for its fiscal fourth quarter on Thursday. To read the full news, click here.
- Progress Software Corporation (NASDAQ: PRGS) reported stronger-than-expected earnings for its fiscal third quarter. However, the company reported downbeat quarterly revenue and lowered its revenue forecast for the full year. To read the full news, click here.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.